Baxter International Inc (BAX)
$34.02 -0.21 (-0.61%)Market Cap | 17.56B |
Revenue (ttm) | 10.64B |
Net Income (ttm) | -649.00M |
EPS (ttm) | N/A |
PE Ratio | 12.45 |
Forward PE | 13.58 |
Profit Margin | -6.10% |
Debt to Equity Ratio | 1.87 |
Volume | 3,495,868 |
Avg Vol | 4,754,230 |
Day's Range | N/A - N/A |
Shares Out | 512.92M |
Stochastic %K | 71% |
Beta | 0.60 |
Analysts | Sell |
Price Target | $37.68 |
Latest News on BAX

Mar 26, 2025, 9:00 AM EDT - 6 days ago
Baxter to Host Annual Meeting of Stockholders in Virtual Format


Mar 4, 2025, 9:00 AM EST - 4 weeks ago
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings


Feb 25, 2025, 4:15 PM EST - 5 weeks ago
Baxter to Present at Barclays 27th Annual Global Healthcare Conference

Feb 20, 2025, 12:42 PM EST - 5 weeks ago
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript

Feb 20, 2025, 12:41 PM EST - 5 weeks ago
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook

Feb 20, 2025, 8:17 AM EST - 5 weeks ago
Baxter forecasts 2025 profit above estimates on medical device demand; shares rise

Feb 18, 2025, 4:15 PM EST - 6 weeks ago
Baxter to Present at TD Cowen 45th Annual Health Care Conference

Feb 17, 2025, 4:15 PM EST - 6 weeks ago
Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference

Feb 13, 2025, 4:15 PM EST - 6 weeks ago
Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day


Feb 3, 2025, 9:26 AM EST - 2 months ago
Baxter CEO José Almeida to retire after near decade-long tenure

Jan 22, 2025, 4:15 PM EST - 2 months ago
Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors

Dec 18, 2024, 4:15 PM EST - 3 months ago
Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 11, 2024, 8:00 AM EST - 3 months ago
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.

Dec 5, 2024, 2:04 PM EST - 4 months ago
Baxter resumes dialysis solution production at its hurricane-hit facility

Nov 19, 2024, 4:15 PM EST - 4 months ago
Baxter to Present at 7th Annual Evercore HealthCONx Conference

Nov 13, 2024, 4:15 PM EST - 4 months ago
Baxter to Present at Jefferies London Healthcare Conference

Nov 8, 2024, 12:16 PM EST - 5 months ago
Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 9:41 AM EDT - 5 months ago
Oneview Healthcare and Baxter International Extend Value-Added Reseller Agreement for Two More Years and Expand the Agreement to include Canada

Oct 24, 2024, 11:43 AM EDT - 5 months ago
Baxter expects to restart IV solutions manufacturing line within next week

Oct 21, 2024, 1:41 PM EDT - 5 months ago
Baxter aims to restore new dialysis patient access to pre-hurricane levels by year-end

Oct 17, 2024, 1:15 PM EDT - 5 months ago
Baxter to import 18,000 tons of IV products to US by year-end

Oct 16, 2024, 4:15 PM EDT - 5 months ago
Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors

Oct 14, 2024, 9:14 AM EDT - 6 months ago
Baxter Is A Strong Buy: The Turnaround Story You Can't Ignore

Oct 9, 2024, 3:39 PM EDT - 6 months ago
Baxter International (BAX) Reports Impact of Hurricane Helene on North Cove Facility

Sep 30, 2024, 6:07 PM EDT - 6 months ago
Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina

Sep 29, 2024, 4:00 PM EDT - 6 months ago
Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community

Sep 26, 2024, 7:30 AM EDT - 6 months ago
Baxter Launches Next Generation of The Vest System for Airway Clearance

Sep 19, 2024, 7:00 AM EDT - 6 months ago
5 Incredible Healthcare High-Yield Blue-Chip Bargain Buys For 2025

Aug 28, 2024, 4:15 PM EDT - 7 months ago
Baxter to Present at 2024 Wells Fargo Healthcare Conference

Aug 19, 2024, 4:15 PM EDT - 8 months ago
Baxter To Sell Its Kidney Care Unit To Carlyle For $3.8 Billion

Aug 13, 2024, 11:43 AM EDT - 8 months ago
Baxter Stock Falls After it Unloads Kidney Care Division in $3.8B Deal

Aug 13, 2024, 11:07 AM EDT - 8 months ago
Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment

Aug 13, 2024, 7:13 AM EDT - 8 months ago
Baxter to sell its kidney care business in a $3.8 billion deal to Carlyle Group

Aug 13, 2024, 7:04 AM EDT - 8 months ago
Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion

Aug 13, 2024, 7:00 AM EDT - 8 months ago